RMD Q2 2019 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q2 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$651M+8.3% YoY

Gross Profit

$384M58.9% margin

Operating Income

$157M24.1% margin

Net Income

$125M19.1% margin

EPS (Diluted)

$0.86

QoQ Revenue Growth

+10.7%

Cash Flow

Operating Cash Flow

$129M

Free Cash Flow

$109M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$3.9B

Total Liabilities

$1.9B

Stockholders' Equity

$2.0B

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$651M	$601M	+8.3%
Gross Profit	$384M	$350M	+9.7%
Operating Income	$157M	$146M	+7.6%
Net Income	$125M	$10M	+1208.3%

Revenue Segments

Devices And Masks

$588M90%

Software As Service

$63M10%

Geographic Segments

Global

$651M50%

Us Canada And Latin America

$422M32%

Combined Europe Asia And Other Markets

$229M18%